跳至主要内容
临床试验/ITMCTR2024000055
ITMCTR2024000055招募中1 期

the influence of traditional Chinese medicine on the frequency and median recurrence time of dupilumab for patients with moderate and severe atopic dermatitis

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
6 至 65(—)
性别
All

入选标准

  • (1) meet the diagnostic criteria of Hanifin and Rajka.
  • (2) No sex limit, age 6-65 years old
  • (3) patients with moderate and severe atopic dermatitis, eczema area and severity index (EASI) = 7 or IGA score = 3
  • (4) the patient himself or his agent agrees to be treated with dupilumab.
  • (5) patients whose blood system, liver, kidney, heart and other systems are basically normal.
  • (6) patients with good compliance, who can be injected with dupilumab at a specified time and fill in the data such as the scale regularly.

排除标准

  • (1) patients with other skin diseases such as scabies, psoriasis, seborrheic dermatitis that affect the judgment of skin lesions.
  • (2) patients suffering from mental diseases, malignant tumors, diabetes and heart disease, pregnant and lactating women.

研究者

发起方
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

相似试验